ReviewProbiotics and antimicrobial proteins2026
Paraprobiotics in Modern Broiler Production: Stability, Safety, and Multifunctional Benefits - a Comprehensive Review.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The growing restrictions on in-feed antibiotics and the global rise of antimicrobial resistance have intensified the demand for safe and sustainable alternatives to support animal health and productivity. Paraprobiotics, defined as non-viable or inactivated bacterial cells, have recently emerged as a promising class of functional bioactives capable of conferring health benefits without the risks associated with live probiotics. Unlike conventional probiotics, paraprobiotics mediate their effects through intact cell structures and microbial metabolites that engage host pattern-recognition receptors, thereby modulating both innate and adaptive immune responses. This review critically examines the antimicrobial efficacy of paraprobiotics in poultry, emphasizing their mechanistic role in maintaining gut barrier integrity, regulating microbial ecology, and mitigating inflammation-induced oxidative stress. Evidence indicates that paraprobiotics suppress pathogenic colonization enhance epithelial function, stimulating antimicrobial peptide production, and improve nutrient utilization and growth performance. Moreover, their stability during feed processing, prolonged shelf-life, and minimal risk of horizontal gene transfer further enhance their suitability for large-scale, intensive production systems. Additionally, emerging inactivation technologies, optimized dosing strategies, and synergistic applications with prebiotics and phytobiotics offer avenues to maximize their functional potential. Collectively, paraprobiotics exemplify a paradigm shift in antimicrobial nutrition providing "dead cells with living functions" that combine safety, efficacy, and sustainability. Their integration into antibiotic-free poultry system hold significant promise for enhancing disease resilience, productive performance and overall sustainability of modern poultry production.
Indexed as
Identifiers
42207421What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.